Printer Friendly

INDUSTRY IS DEVELOPING 263 MEDICINES FOR USE IN WOMEN

 INDUSTRY IS DEVELOPING 263 MEDICINES FOR USE IN WOMEN
 TALLAHASSEE, Fla., Feb. 4 /PRNewswire/ -- A new survey has found


that 263 medicines are in human clinical trials or awaiting approval at the Food and Drug Administration for diseases that exclusively or disproportionately affect women or are the top 10 causes of death in women. The survey was conducted by the Pharmaceutical Manufacturers Association (PMA).
 "With 79 companies involved in these research projects, virtually every major pharmaceutical company is addressing the need to develop medicines in a way that takes into account the special medical needs of women," PMA Regional Director Paul Emrick said today at a seminar on women's health issues.
 Essential metabolic differences between men and women can create important differences in their ability to metabolize, absorb and transport drugs to key areas of the body. The possibility of pregnancy and damage to the fetus are other important considerations when testing drugs in women.
 "As a legislator concerned about women's health issues, I am pleased that pharmaceutical companies are doing the research that addresses the unique medical needs of women," Florida State Sen. Helen Gordon Davis told seminar participants.
 "I urge the industry to continue to work hard to develop drugs for women," said Davis, who chairs the Health and Rehabilitative Services Subcommittee.
 Key findings in the survey report, called "New Medicines in Development for Women," include:
 -- In testing for breast cancer are 37 medicines -- more than for any other disease of women. More than 18,000 women in Florida have breast cancer and 2,700 died of it last year.
 -- The top three major categories of research are cardiovascular/cerebrovascular diseases with 48 medicines in development, cancer with 58 and obstetric and gynecologic diseases with 51.
 -- The top three causes of death among women in Florida -- heart disease, cancer and stroke -- are the focus of 40 percent of the research. More than 21,000 women in the state died of heart disease in 1990 alone, and nearly 5,000 died of stroke.
 -- Lung cancer has 29 medicines in development. Nearly 4,000 women in Florida died of lung cancer in 1990.
 -- Another 37 medicines are in testing for five specific types of arthritis and other musculoskeletal diseases. Nearly 1.2 million women in Florida have arthritis.
 The report contains a list of the medicines in development, the companies developing them, the diseases for which they are being tested and their development status. Each medicine listed is either being tested to see if it should be developed for use in women or specifically includes women in clinical trials.
 The Pharmaceutical Manufacturers Association is a non-profit scientific and professional organization of more than 100 member companies that discover, develop and produce most of the prescription drugs used in the United States.
 -0- 2/4/92
 /NOTE: Copies of the survey report are available free of charge by writing: New Medicines in Development for Women, Pharmaceutical Manufacturers Association, 1100 15th St., N.W., Washington, D.C. 20005/
 /CONTACT: Judith Shuler of the Pharmaceutical Manufacturers Association, 904-656-2137/ CO: Pharmaceutical Manufacturers Association ST: Florida IN: MTC SU:


TW -- DC035 -- 6913 02/04/92 17:30 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 4, 1992
Words:523
Previous Article:STANDARD & POOR'S STOCK PRICE INDEX -- CLOSING, TUESDAY FEB. 4 /PRN/
Next Article:DODGE VIPER WINS HIGHEST AWARD IN THE COMPOSITES INDUSTRY
Topics:


Related Articles
PHARMACEUTICAL INDUSTRY DEVELOPS 263 MEDICINES FOR USE IN WOMEN
In vitro fertilization: the pluses add up.
PhyMatrix Acquires The Crucible Group - Broadens Clinical Studies' Reach Within Women's Health Studies -.
CRN Reaffirms Vitamin A Intake Levels as Safe and Beneficial; - Urges Continued Support of IOM Policy on Upper Limits -.
Patients with bipolar illness admitted to a general medical service.
Teva-Tuteur to Market and Distribute Immunomedics' Diagnostic Imaging Products in Latin America.
Internationally Recognized Keynote Speakers Add to Appeal of Medical Conference; COHRI Boasts Success at Alamo.
Endo Pharmaceuticals and Drexel Team Up on New Health Initiative.
Sports medicine: the last 100 years.
High-carb Chinese diet may hike diabetes risk.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters